172 related articles for article (PubMed ID: 36845294)
1. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
[TBL] [Abstract][Full Text] [Related]
2. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
4. Conditional Recurrence-Free Survival After Surgical Resection of Meningioma.
Tang AR; Chotai S; Guidry BS; Sun L; Ye F; Kelly PD; McDermott JR; Grisham CJ; Morone PJ; Thompson RC; Chambless LB
Neurosurgery; 2023 Aug; 93(2):339-347. PubMed ID: 36815800
[TBL] [Abstract][Full Text] [Related]
5. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.
Nanda A; Bir SC; Maiti TK; Konar SK; Missios S; Guthikonda B
J Neurosurg; 2017 Jan; 126(1):201-211. PubMed ID: 27058201
[TBL] [Abstract][Full Text] [Related]
6. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
7. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
[TBL] [Abstract][Full Text] [Related]
8. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
9. Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma.
Anand SK; Sardari H; Sadeghsalehi A; Bagheri SR; Eden SV; Lawton MT; Alimohammadi E
Neurol Res; 2022 May; 44(5):468-474. PubMed ID: 34967283
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
12. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas in children and adolescents: a meta-analysis of individual patient data.
Kotecha RS; Pascoe EM; Rushing EJ; Rorke-Adams LB; Zwerdling T; Gao X; Li X; Greene S; Amirjamshidi A; Kim SK; Lima MA; Hung PC; Lakhdar F; Mehta N; Liu Y; Devi BI; Sudhir BJ; Lund-Johansen M; Gjerris F; Cole CH; Gottardo NG
Lancet Oncol; 2011 Dec; 12(13):1229-39. PubMed ID: 22094004
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Methylation Signatures and
Meta R; Boldt HB; Kristensen BW; Sahm F; Sjursen W; Torp SH
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809258
[No Abstract] [Full Text] [Related]
15. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
16. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
17. A molecularly integrated grade for meningioma.
Driver J; Hoffman SE; Tavakol S; Woodward E; Maury EA; Bhave V; Greenwald NF; Nassiri F; Aldape K; Zadeh G; Choudhury A; Vasudevan HN; Magill ST; Raleigh DR; Abedalthagafi M; Aizer AA; Alexander BM; Ligon KL; Reardon DA; Wen PY; Al-Mefty O; Ligon AH; Dubuc AM; Beroukhim R; Claus EB; Dunn IF; Santagata S; Bi WL
Neuro Oncol; 2022 May; 24(5):796-808. PubMed ID: 34508644
[TBL] [Abstract][Full Text] [Related]
18. A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Aizer AA; Abedalthagafi M; Bi WL; Horvath MC; Arvold ND; Al-Mefty O; Lee EQ; Nayak L; Rinne ML; Norden AD; Reardon DA; Wen PY; Ligon KL; Ligon AH; Beroukhim R; Dunn IF; Santagata S; Alexander BM
Neuro Oncol; 2016 Feb; 18(2):269-74. PubMed ID: 26323607
[TBL] [Abstract][Full Text] [Related]
19. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
20. Surgical Treatment and Predictive Factors for Atypical Meningiomas: A Multicentric Experience.
Dobran M; Marini A; Splavski B; Rotim K; Liverotti V; Nasi D; Iacoangeli M
World Neurosurg; 2020 Dec; 144():e1-e8. PubMed ID: 32311549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
